

LONDON, April 21 (Reuters) - Tate & Lyle on Tuesday said it would exit most of its European bulk ingredients business and restructure its struggling S...


AstraZeneca: Morgan Stanley lifts target price to 4,500p from 4,300p, reiterates underweight. BG Group: Canaccord Genuity improves target price to 1,3...


Numis Securities has lowered its recommendation for Tate & Lyle from 'hold' to 'reduce', saying there is "little to excite" investors of the sweetener...


Oil stocks were in demand on Tuesday as traders played catch-up with gains in crude futures over the last few days. During the weekend Saudi Arabia in...